Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01520389
Show Display Options
Rank Status Study
1 Recruiting Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
Conditions: Advanced Solid Tumors;   Colorectal Cancer;   Squamous Cell Head and Neck Cancer;   Non Small Cell Lung Cancer;   Triple Negative Breast Cancer
Interventions: Drug: MM-151;   Drug: MM-151 + irinotecan

Indicates status has not been verified in more than two years